A critical review of the TRAM flap for the mastectomy patient
Deric K. E. van der Schoot(Amphia Ziekenhuis), A. N. Posma(Leiden University), R. J. Zeeman(Leiden University), W Roos(Leiden University)
Cited by 7
Related Papers
Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial
|The Lancet Oncology|2017|158
DEGENERATIVE CHANGES AT THE KNEE AND ANKLE RELATED TO MALUNION OF TIBIAL FRACTURES
|Journal of Bone and Joint Surgery - British Volume|1996|123
Non–muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-Guérin
|Science Translational Medicine|2023|89
Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients
|Urologic Oncology Seminars and Original Investigations|2021|39